Plain-English translation of NCT07732738 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Obesity research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether weight loss surgery works better when combined with semaglutide, an injectable medication that helps reduce appetite and weight. Researchers want to see if adding this medication after surgery helps patients lose more weight and improves their overall health, compared to surgery alone. The study will involve 400 patients across multiple hospitals in China.
While weight loss surgery is very effective, some patients regain weight over time or don't see all the health improvements they hoped for. This study exists to see whether the new treatment can help prevent weight regain and improve long-term results after surgery.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will have weight loss surgery (a laparoscopic sleeve gastrectomy). After surgery, you will either receive weekly injections of the medication for six months while following basic nutritional guidance, or follow basic nutritional guidance alone. Throughout the six-month period, the research team will monitor your weight loss, health improvements, and any side effects to see how well the combination treatment works compared to surgery alone.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
China